Virta Health

Healthcare

Founded: 2014

Last Round Valuation: $2.12B

Established in 2014, Virta Health is a healthcare firm dedicated to creating an evidence-based remedy for type 2 diabetes and other persistent metabolic disorders. Their innovative treatment approach aims to safely and effectively reverse these conditions without resorting to medications or surgical interventions. Combining advanced technology, medical knowledge, and tailored guidance, Virta Health is committed to supporting patients in attaining optimal health outcomes and enhancing their overall well-being. Headquartered in San Francisco, California, the company is driven by a mission to empower individuals on their journey towards improved health and a higher quality of life.

Virta Health Overview:

Virta Health, founded in 2014, is a leading healthcare company that specializes in developing a clinically-proven and innovative treatment for type 2 diabetes and other chronic metabolic diseases. The company's approach focuses on safely and sustainably reversing these conditions without the need for medications or surgical interventions.

Virta Health's treatment program is rooted in the principles of nutritional ketosis, where the body shifts from relying on carbohydrates to utilizing fat as its primary fuel source. By adopting a low-carbohydrate, high-fat diet, combined with continuous remote care and personalized coaching, patients can achieve significant improvements in their metabolic health.

The core of Virta Health's solution lies in their unique combination of advanced technology, medical expertise, and ongoing support. Through their proprietary digital platform, patients have access to a comprehensive suite of tools, including a mobile app, educational resources, and real-time tracking of health markers such as blood glucose levels and weight.

In addition to the technological aspects, Virta Health's team of healthcare professionals, including physicians, registered dietitians, and health coaches, provide personalized guidance and support to each patient. This multidisciplinary approach ensures that individuals receive tailored care based on their specific needs, goals, and medical history.

The company's mission is to help patients achieve long-term, sustainable improvements in their health and well-being. By empowering individuals with the knowledge, tools, and ongoing support necessary to make positive lifestyle changes, Virta Health aims to not only reverse type 2 diabetes and metabolic diseases but also enhance overall health outcomes and quality of life.

Headquartered in San Francisco, California, Virta Health has gained significant recognition and has been at the forefront of groundbreaking research in the field of metabolic health. The company continues to advance the understanding and treatment of type 2 diabetes through clinical studies, collaborations with leading research institutions, and ongoing innovation.

Virta Health's commitment to evidence-based care, personalized coaching, and continuous support sets them apart as a pioneer in the field of metabolic health. Their comprehensive approach, combining technology, medical expertise, and patient empowerment, has the potential to transform the lives of millions of individuals living with type 2 diabetes and other chronic metabolic diseases.

Founders:

  • Jeff Volek Ph.D

  • Sami Inkinen Ph.D

  • Stephen Phinney Ph.D

Top Investors:

  • Allen & Company

  • Bronze VC

  • CG Health Ventures

  • Caffeinated Capital

  • Creandum

  • Founders Fund

  • Obvious Ventures

  • Playground Global

  • SciFi VC

  • Sequoia Capital Global Equities

  • Tiger Global Management

  • Venrock

Funding History:


Date Share Type Amount Raised Raised to Date Issue Price Post Money Valuation Key Investors
Apr 2021 Series E $132.84MM $364.48MM $3.10 $2.12B Tiger Global Management
Dec 2020 Series D-1 $34.88MM $201.64MM $1.74 $1.16B Sequoia Capital Global Equities, Caffeinated Capital
Dec 2020 Series D $30MM $196.77MM $1.94 $1.16B Sequoia Capital Global Equities, Caffeinated Capital
Aug 2019 Series C $65MM $138.58MM $0.92 $515.08MM Caffeinated Capital, Venrock, Obvious Ventures
Aug 2019 Series C-1 $28.19MM $101.77MM $0.68 $515.08MM Caffeinated Capital, Venrock, Obvious Ventures
Apr 2018 Series B $42.5MM $73.58MM $0.56 $238.63MM Venrock, Obvious Ventures, Creandum
Jul 2016 Series A-1 $7.64MM $7.64MM $0.26 $171.66MM Allen & Company, Bronze VC, Caffeinated Capital
Jul 2016 Series A $23.43MM $23.43MM $0.37 $171.66MM Allen & Company, Bronze VC, Caffeinated Capital

In the News: